Research Beagle Facility Ordered to Clean Up, Halt Breeding

A federal judge ruled that Envigo can finalize the sales for 500 of its remaining 3,000 research dogs, but it needs to improve the safety and health of the animals remaining at its facilities while federal officials decide their fate.

Written byAndy Carstens
| 2 min read
beagle
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The US District Court in West Virginia issued a preliminary injunction on Friday (June 17) allowing Envigo to fulfill existing contracts to sell some of the beagles reared in its Cumberland, Virginia facility but prohibiting it from breeding new puppies, reports the Associated Press. Envigo wants to sell all of the dogs, according to Science, while the US Department of Justice (DOJ) argues it should only be allowed to give them away until the facility fully complies with Animal Welfare Act (AWA) requirements, which it currently doesn’t.

“To be clear, Defendant is not being given a free pass,” Judge Norman K. Moon wrote in the order, adding that “punitive consequences, including financial consequences, may follow from this litigation after a final judgment on the merits.”

After the United States Department of Agriculture (USDA) reported more than 70 Animal Welfare Act (AWA) violations at Envigo’s beagle breeding facility in Cumberland, Virginia, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens is a freelance science journalist who is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has previously appeared in AudubonSlateThem, and Aidsmap. View his full portfolio at www.andycarstens.com.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies